Greenline Biofarms Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.91 M
as on 19-12-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.00 Cr
as on 19-12-2024
- Satisfied Charges ₹ 58.17 Cr
as on 19-12-2024
- Revenue -1.97%
(FY 2022)
- Profit -14.05%
(FY 2022)
- Ebitda -28.94%
(FY 2022)
- Net Worth 0.94%
(FY 2022)
- Total Assets -0.30%
(FY 2022)
About Greenline Biofarms
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.91 M.
The company currently has active open charges totaling ₹12.00 Cr. The company has closed loans amounting to ₹58.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
Hanuman Khedaria, Alka Kadmawala, Ayush Khedaria, and One other member serve as directors at the Company.
- CIN/LLPIN
U01122OR2004PTC007685
- Company No.
007685
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Sundergarh, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Greenline Biofarms?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hanuman Khedaria  | Director | 21-Jul-2004 | Current |
| Alka Kadmawala | Director | 30-Jan-2020 | Current |
| Ayush Khedaria | Director | 03-Jan-2018 | Current |
| Hanuman Agarwal | Director | 01-Nov-2022 | Current |
Financial Performance and Corporate Structure Insights of Greenline Biofarms.
Greenline Biofarms Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.97% decrease. The company also saw a substantial fall in profitability, with a 14.05% decrease in profit. The company's net worth moved up by a moderate rise of 0.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Greenline Biofarms?
In 2021, Greenline Biofarms had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 01 Aug 2022 | ₹12.00 Cr | Open |
Indian Overseas Bank Creation Date: 10 Jul 2023 | ₹39.52 Cr | Satisfied |
State Bank Of India Creation Date: 29 Feb 2020 | ₹1.00 M | Satisfied |
How Many Employees Work at Greenline Biofarms?
Unlock and access historical data on people associated with Greenline Biofarms, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Greenline Biofarms, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Greenline Biofarms's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
